
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
BACE2 CRISPR/Cas9 KO Plasmid (m) | sc-425013 | 20 µg | $397.00 |
Bace2 encodes the mouse β-site APP-cleaving enzyme 2 (BACE2), a type I transmembrane aspartyl protease that participates in regulated intramembrane proteolysis of select substrates in the secretory and endosomal pathways. BACE2 activity influences proteostasis and membrane protein processing, intersecting with vesicular trafficking, lysosomal turnover, and cellular stress responses linked to neuronal and metabolic physiology. In the central nervous system, BACE2 has been studied in the context of amyloid precursor protein family processing and peptide generation, informing research on pathways implicated in neurodegeneration. In peripheral tissues, including pancreatic islets, BACE2-associated substrate cleavage has been connected to β-cell function, making it relevant for mechanistic studies of metabolic disease biology.
BACE2 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Bace2 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Bace2 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Bace2 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish BACE2 protein expression.
This CRISPR knockout system enables efficient generation of Bace2-deficient cell models for investigation of BACE2 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.